Safety And Efficacy Study Of Orally Administered DS102 In Patients With NAFLD
Status:
Completed
Trial end date:
2019-01-02
Target enrollment:
Participant gender:
Summary
The purpose of this randomised, double-blind, placebo-controlled, parallel group study is to
assess the safety and efficacy of orally administered DS102 capsules versus placebo in the
treatment of adult patients with Non Alcoholic Fatty Liver Disease (NAFLD)